Ordering
Available Variants10 mg
CHA.53534-10mg
Price
€88.80
Available – Dispatch in 14 days
50 mg
CHA.53534-50mg
Price
€281.60
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.53534-10mg | €88.80 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.53534-50mg | €281.60 |
analytical standard
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C10H19NO4 |
|---|---|
| CAS Number | 20064-19-1 |
| Molecular Weight | 217.26 |
| UNSPSC Code | 41116107 |
| NACRES | NB.21 |
| MDL number | MFCD00870024 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Propionyl-L-carnitine, with the chemical formula C₇H₁₅NO₄S and CAS number 20064-19-1, is a naturally occurring compound that plays a crucial role in the transportation of fatty acids into the mitochondria for energy production. It is an acyl derivative of L-carnitine, which is a vital molecule in the process of beta-oxidation. Propionyl-L-carnitine has been shown to have various pharmacological effects, including improving exercise performance, enhancing blood flow, and exerting antioxidant properties. Its potential therapeutic applications include the treatment of cardiovascular diseases, such as intermittent claudication and heart failure, as well as neurodegenerative disorders like Alzheimers disease. Further research is needed to fully elucidate the mechanisms of action and potential benefits of propionyl-L-carnitine, but existing evidence suggests that it may be a valuable adjunctive therapy for a range of conditions.
